glp-1 gip therapy effectiveness muscle loss 🔬 GLP-1/GIP Discontinuation: Why the “How” Matters One of the most-discussed challenges with GLP-1/GIP agonists such as tirzepatide (Mounjaro®) is weight regain after stopping therapy. What… | Paramesh Shamanna TrimRX | GLP-1 vs GIP:

Appropriate Rate of Weight Loss Target: 0.5-1% of body weight per week maximum While GLP-1s can drive faster weight loss, slower is better for muscle preservation

Given the emerging concern around potential muscle loss, strategies to mitigate reductions in FFM during pharmacologically induced BW loss should be prioritized

Beginning with THF, the serine/glycine hydroxymethyltransferases encoded by the SHMT1 and SHMT2 genes generate 5,10-methylene-THF ( N 5 , N 10 -methylene-THF)

What Are Copper Peptides and Why Are They Used

Consistent, repeatable habits paired with scheduled follow-ups produce the most durable results